The First Hybrid Quality Measure Is Here, And Yes, It’s Going to Shake Things Up
What MDS Coordinators need to know (and do) right now. If you’ve heard the buzz about CMS’ first-ever hybrid quality measure, the Long-Stay Antipsychotic Medication QM, you’re probably wondering: “How will this impact our quality scores? And why does it feel like half the data will come from places I don’t even control?” You’re not … Continue reading
